# Carvedilol Versus Placebo for Treatment in Post Traumatic Stress Disorder (PTSD)

> **NCT01221792** · PHASE2 · UNKNOWN · sponsor: **Columbia Northwest Pharmaceuticals** · enrollment: 80 (estimated)

## Conditions studied

- Post-Traumatic Stress Disorder

## Interventions

- **DRUG:** Carvedilol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01221792
- **Lead sponsor:** Columbia Northwest Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2011-06
- **Final completion:** 2011-08
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2011-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01221792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01221792, "Carvedilol Versus Placebo for Treatment in Post Traumatic Stress Disorder (PTSD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01221792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*